Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Health Catalyst (HCAT) Gross Margin (2018 - 2025)

Health Catalyst (HCAT) has disclosed Gross Margin for 8 consecutive years, with 47.37% as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Gross Margin rose 15.0% year-over-year to 47.37%, compared with a TTM value of 55.47% through Jun 2025, up 1833.0%, and an annual FY2023 reading of 44.55%, down 367.0% over the prior year.
  • Gross Margin was 47.37% for Q2 2025 at Health Catalyst, up from 45.63% in the prior quarter.
  • Across five years, Gross Margin topped out at 85.15% in Q3 2024 and bottomed at 51.9% in Q4 2023.
  • Average Gross Margin over 5 years is 48.89%, with a median of 49.6% recorded in 2021.
  • The sharpest move saw Gross Margin surged 3585bps in 2022, then crashed -7775bps in 2023.
  • Year by year, Gross Margin stood at 10.0% in 2021, then soared by 358bps to 25.85% in 2022, then crashed by -301bps to 51.9% in 2023, then soared by 264bps to 85.15% in 2024, then tumbled by -44bps to 47.37% in 2025.
  • Business Quant data shows Gross Margin for HCAT at 47.37% in Q2 2025, 45.63% in Q1 2025, and 85.15% in Q3 2024.